- Home
- » Tags
- » Mitotic inhibitor
Top View
- Ramucirumab for the Treatment of Gastric Cancer Rapid
- Paclitaxel and CYC3, an Aurora Kinase a Inhibitor, Synergise in Pancreatic Cancer Cells but Not Bone Marrow Precursor Cells
- Drugs Against Cancer: Stories of Discovery and the Quest for a Cure
- Antifungals of the Azole Type
- Breast Systemic Treatment
- Cell Cycle/DNA Damage
- Decreased Expression of Kru¨Ppel-Like Factors in Memory B Cells Induces the Rapid Response Typical of Secondary Antibody Responses
- 6Α-Acetoxyanopterine: a Novel Structure Class of Mitotic Inhibitor Disrupting
- Taxotere® (Docetaxel) Injection Concentrate, 20 Mg/Ml and 80 Mg
- Mitosis in Cancer Cell Increases Immune Resistance Via High Expression of HLA-G and PD-L1
- Supplementary Table 1. Summary of FDA-Approved Anticancer Cytotoxic Drugs at May 2019
- UA62784, a Novel Inhibitor of Centromere Protein E Kinesin-Like Protein
- Preclinical Studies for the Combination of Paclitaxel and Curcumin in Cancer Therapy (Review)
- Increased Therapeutic Potential of an Experimental Anti-Mitotic Inhibitor SB715992 by Genistein in PC-3 Human Prostate Cancer Cell Line David A
- 3.1 Basic Principles of Chemotherapy
- Inhibition of Microtubules and Cell Cycle Arrest by a New 1-Deaza-7,8- Dihydropteridine Antitumor Drug, CI 980, and by Its Chiral Isomer, NSC 6138631
- Bioactive Fungal Natural Products from Extremophilic Endophytes
- Effects of 3D Microenvironments on Drug Efficacy to Breast Cancer Cell
- Overview of Cancer Therapy
- Nanomedicine in Non-Small Cell Lung Cancer: from Conventional Treatments to Immunotherapy
- A Putative Inhibitor of CENP-E Kinesin-Like Protein and Its Effects on Human Pancreatic Cancer Cells
- Peripheral Blood Karyotyping Solutions Brochure / 0718 It’S All About Understanding Genetics
- Activation of P53 by MDM2 Antagonists Can Protect Proliferating Cells from Mitotic Inhibitors
- Targeting Mitosis Exit a Brake for Cancer Cell Proliferation
- Report Number of Nuclear Divisions in the Drosophila Blastoderm Controlled by Onset of Zygotic Transcription
- Role of Polo-Like Kinase in the Degradation of Early Mitotic Inhibitor 1, a Regulator of the Anaphase Promoting Complex Cyclosom
- A Novel Synthetic Microtubule Inhibitor Exerts Antiproliferative Effects In
- A Bacterial Effector Targets Mad2l2, an APC Inhibitor, to Modulate Host Cell Cycling
- The Mitotic Inhibitor Ccs52 Is Required for Endoreduplication and Ploidy-Dependent Cell Enlargement in Plants
- Tyrosine Phosphatases That Negatively Regulate Mitosis SABINE OTTILIE,1 JONATHAN CHERNOFF,1T GERHARD HANNIG,1 CHARLES S
- Combined Antimicrotubule Activity of Estramustine and Taxol in Human Prostatic Carcinoma Cell Lines1
- Investigating the Effects of Particulate Hexavalent Chromium on the Centriole Linkers Julieta Martino
- Leveraging Multi-Way Interactions for Systematic Prediction of Drug Combination Effects
- HUMAN CYTOGENETICS Prenatal Diagnostics Peripheral Blood Bone Marrow Auxiliary Products
- Microtubule Depolymerization by Kinase Inhibitors: Unexpected Findings of Dual Inhibitors
- United States Patent (19) 11 Patent Number: 4,515,794 Emery Et Al
- Functional Inactivation of Prb Results in Aneuploid Mammalian Cells After Release from a Mitotic Block1
- Anticancer Therapeutics